O'Shaughnessy Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $16,513 - $20,359	-255 Reduced 6.49%	3,674 $251,000
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $4,827 - $5,673	75 Added 1.95%	3,929 $271,000
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $178,709 - $283,847	3,854 New	3,854 $276,000
Q4 2022 Feb 10, 2023	BUY	$44.07 - $54.45 $174,957 - $216,166	3,970 New	3,970 $210,000
Q2 2022 Aug 11, 2022	BUY	$43.0 - $65.64 $258 - $393	6 Added 0.15%	4,084 $233,000
Q1 2022 May 13, 2022	BUY	$38.74 - $62.09 $157,981 - $253,203	4,078 New	4,078 $250,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.